Summit, Japanese pharmacology, hormones, therapy
Summit International Pharmaceutical Company was founded in 1949 in Japan. The company develops and realize as finished products, as the main components to them. A wide range of activities also captures the production of biologically active components, products for cosmetology and sports pharmacology.
Summit is part of a powerful enterprise group with many partners in the United States, Canada and all Europe. This makes easy to maintain business relationships with many partners and develop in pharmaceutical industry.
Compared with its competitors, their medical unit is small and covers about 150 people. However, such small staff is capable to provide sufficiently powerful manufacturing, since modern equipment is used and virtually the entire production process is automated.
Modern laboratories for quality control equipped with the latest standards, so it eliminates the possibility of penetration of low-quality products.
The company produces drugs used in sports pharmacology, such as:
Stanozolol (in tablets and for injection);
Liothyronine Sodium (synthetic analogue of thyroid hormones);
Testosterone (with the adding of different half-life duration esters).
Summit is a company that conquers the consumer market around the world more and more every year.